Abstract
Sustainable correction of severe human genetic disorders of self-renewing tissues, such as the blistering skin disease junctional epidermolysis bullosa (JEB), is facilitated by stable genomic integration of therapeutic genes into somatic tissue stem cells. While integrating viral vectors can achieve this, they suffer from logistical and biosafety concerns. To circumvent these limitations, we used the Sleeping Beauty transposable element to integrate the LAMB3 cDNA into genomes of epidermal holoclones from six unrelated JEB patients. These cells regenerate human JEB skin that is normalized at the level of laminin 5 protein expression, hemidesmosome formation and blistering. Transposon-mediated gene delivery therefore affords an opportunity for stable gene delivery in JEB and other human diseases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
Purchase on Springer Link
Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Deng H, Lin Q, Khavari PA . Sustainable cutaneous gene delivery. Nat Biotechnol 1997; 15: 1388–1391.
Robbins PB et al. In vivo restoration of laminin 5 beta 3 expression and function in junctional epidermolysis bullosa. Proc Natl Acad Sci USA 2001; 98: 5193–5198.
Choate KA, Khavari PA . Direct cutaneous gene delivery in a human genetic skin disease. Hum Gene Ther 1997; 8: 1671–1677.
Hengge UR et al. Cytokine gene expression in epidermis with biological effects following injection of naked DNA. Nat Genet 1995; 10: 161–166.
Hengge UR, Walker PS, Vogel JC . Expression of naked DNA in human, pig, and mouse skin. J Clin Invest 1996; 97: 2911–2916.
Izsvak Z, Ivics Z, Plasterk RH . Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates. J Mol Biol 2000; 302: 93–102.
Yant SR et al. Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system. Nat Genet 2000; 25: 35–41.
Richardson PD, Augustin LB, Kren BT, Steer CJ . Gene repair and transposon-mediated gene therapy. Stem Cells 2002; 20: 105–118.
Plasterk RH . The Tc1/mariner transposon family. Curr Top Microbiol Immunol 1996; 204: 125–143.
Ivics Z, Hackett PB, Plasterk RH, Izsvak Z . Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 1997; 91: 501–510.
Marinkovich MP, Herron GS, Khavari PA, Bauer EA . Hereditary epidermolysis bullosa. In: Freedberg IM et al (eds). Dermatology in General Medicine, Vol. I. McGraw-Hill: New York, 1999, pp 690–702.
Pulkkinen L et al. A homozygous nonsense mutation in the beta 3 chain gene of laminin 5 (LAMB3) in Herlitz junctional epidermolysis bullosa. Genomics 1994; 24: 357–360.
Niessen CM et al. The alpha 6 beta 4 integrin is a receptor for both laminin and kalinin. Exp Cell Res 1994; 211: 360–367.
Rousselle P et al. Laminin 5 binds the NC-1 domain of type VII collagen. J Cell Biol 1997; 138: 719–728.
Ryan MC, Lee K, Miyashita Y, Carter WG . Targeted disruption of the LAMA3 gene in mice reveals abnormalities in survival and late stage differentiation of epithelial cells. J Cell Biol 1999; 145: 1309–1323.
Deng H, Choate KA, Lin Q, Khavari PA . High efficiency gene transfer and pharmacologic selection of genetically engineered human keratinocytes. BioTechniques 1998; 25: 274–280.
Robbins PB, Sheu SM, Goodnough JB, Khavari PA . Impact of laminin 5 beta3 gene versus protein replacement on gene expression patterns in junctional epidermolysis bullosa. Hum Gene Ther 2001; 12: 1443–1448.
Barrandon Y, Green H . Three clonal types of keratinocyte with different capacities for multiplication. Proc Natl Acad Sci USA 1987; 84: 2302–2306.
Mathor MB et al. Clonal analysis of stably transduced human epidermal stem cells in culture. Proc Natl Acad Sci USA 1996; 93: 10371–10376.
Medalie DA et al. Evaluation of human skin reconstituted from composite grafts of cultured keratinocytes and human acellular dermis transplanted to athymic mice. J Invest Dermatol 1996; 107: 121–127.
Choate KA, Medalie DA, Morgan JR, Khavari PA . Corrective gene transfer in the human skin disorder lamellar ichthyosis. Nat Med 1996; 2: 1263–1267.
Freiberg RA et al. A model of corrective gene transfer in X-linked ichthyosis. Hum Mol Genet 1997; 6: 937–933.
Seitz CS et al. BP180 gene delivery in junctional epidermolysis bullosa. Gene Ther 1999; 6: 42–47.
Dellambra E et al. Gene correction of integrin beta4-dependent pyloric atresia-junctional epidermolysis bullosa keratinocytes establishes a role for beta4 tyrosines 1422 and 1440 in hemidesmosome assembly. J Biol Chem 2001; 276: 41336–41342.
Gagnoux-Palacios L et al. Functional re-expression of laminin-5 in laminin-gamma2-deficient human keratinocytes modifies cell morphology, motility, and adhesion. J Biol Chem 1996; 271: 18437–18444.
Page SM, Brownlee GG . Differentiation-specific enhancer activity in transduced keratinocytes: a model for epidermal gene therapy. Gene Therapy 1998; 5: 394–402.
Kolodka TM, Garlick JA, Taichman LB . Evidence for keratinocyte stem cells in vitro: long term engraftment and persistence of transgene expression from retrovirus-transduced keratinocytes. Proc Natl Acad Sci USA 1998; 95: 4356–4361.
Stockschlader MA, Schuening FG, Graham TC, Storb R . Transplantation of retrovirus-transduced canine keratinocytes expressing the beta-galactosidase gene. Gene Therapy 1994; 1: 317–322.
Freiberg RA, Ho SN, Khavari PA . Transcriptional control in keratinocytes and fibroblasts using synthetic ligands. J Clin Invest 1997; 99: 2610–2615.
Marinkovich MP, Lunstrum GP, Burgeson RE . The anchoring filament protein kalinin is synthesized and secreted as a high molecular weight precursor. J Biol Chem 1992; 267: 17900–17906.
Khavari PA et al. BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription. Nature 1993; 366: 170–174.
Acknowledgements
We thank MP Marinkovich for antibody reagents and helpful discussions at all stages of this work. We also thank F Scholl, Z Siprashvili, A Nguyen, N Griffiths, P Bernstein, PB Robbins and other members of the Khavari Laboratory, Mar-kade foundation, Klaus Wolff Klewens Rappersberger.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ortiz-Urda, S., Lin, Q., Yant, S. et al. Sustainable correction of junctional epidermolysis bullosa via transposon-mediated nonviral gene transfer. Gene Ther 10, 1099–1104 (2003). https://doi.org/10.1038/sj.gt.3301978
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301978
Keywords
This article is cited by
-
From Marrow to Matrix: Novel Gene and Cell Therapies for Epidermolysis Bullosa
Molecular Therapy (2015)
-
Somatic Correction of Junctional Epidermolysis Bullosa by a Highly Recombinogenic AAV Variant
Molecular Therapy (2014)
-
Increased interstitial pressure improves nucleic acid delivery to skin enabling a comparative analysis of constitutive promoters
Gene Therapy (2010)
-
Hybrid Lentivirus-transposon Vectors With a Random Integration Profile in Human Cells
Molecular Therapy (2009)
-
Efficient nonviral Sleeping Beauty transposon-based TCR gene transfer to peripheral blood lymphocytes confers antigen-specific antitumor reactivity
Gene Therapy (2009)